Posttreatment platelet reactiity to clopidogrel measured by ADP-induced light transmittance aggregometry, was lower in diabetic patients (40% s 32%; P = .01).

• 治疗后通过ADP介导的透光率血小板聚集功能测定，糖尿病患者的血小板对氯吡格雷的反应性偏低（40%25对32%25；P＝0.；01）。